FDAnews Drug Daily Bulletin

Aug. 6, 2012 | Vol. 9 No. 153

Sun Pharma to Acquire German Drug Maker Stada

Sun Pharmaceutical is planning acquisitions in Europe and is in talks with German drugmaker Stada Arzneimittel. The overseas acquisition is a part of strategic move to broaden its geographic breadth. Sun Pharma has followed a strategy of acquiring under-performing or unprofitable companies and merging their operations to its company.
DealCurry

Register Now
Print This Page
Email This Article
RSS
Archives

Full Issue FDA Advisers Recommend Merck Insomnia Drug; Downplay Need for Additional Trials Senate Preps Track-and-Trace, Compounding Reform Bills for Floor Vote Ranbaxy Compliance Reforms Reflect FDA Manufacturing Recommendations

Home
Advertising/Sponsorships
About Us
Contact Us
Site Map
Privacy Policy

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.